|
1
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar
|
|
3
|
Fukunaga A, Miyamoto M, Cho Y, et al:
CD8+ tumor-infiltrating lymphocytes together with
CD4+ tumor-infiltrating lymphocytes and dendritic cells
improve the prognosis of patients with pancreatic adenocarcinoma.
Pancreas. 28:e26–e31. 2004.
|
|
4
|
Uehara H, Miyamoto M, Kato K, et al:
Expression of pigment epithelium-derived factor decreases liver
metastasis and correlates with favorable prognosis for patients
with ductal pancreatic adenocarcinoma. Cancer Res. 64:3533–3537.
2004. View Article : Google Scholar
|
|
5
|
Sakurai T, Yanagisawa M, Takuwa Y, et al:
Cloning of a cDNA encoding a non-isopeptide-selective subtype of
the endothelin receptor. Nature. 348:732–735. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Buckanovich RJ, Facciabene A, Kim S, et
al: Endothelin B receptor mediates the endothelial barrier to T
cell homing to tumors and disables immune therapy. Nat Med.
14:28–36. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nelson JB, Fizazi K, Miller K, et al:
Phase 3, randomized, placebo-controlled study of zibotentan
(ZD4054) in patients with castration-resistant prostate cancer
metastatic to bone. Cancer. 118:5709–5718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller K, Moul JW, Gleave M, et al: Phase
III, randomized, placebo-controlled study of once-daily oral
zibotentan (ZD4054) in patients with non-metastatic
castration-resistant prostate cancer. Prostate Cancer Prostatic
Dis. 16:187–192. 2013.PubMed/NCBI
|
|
9
|
Clézardin P: Therapeutic targets for bone
metastases in breast cancer. Breast Cancer Res. 13:2072011.
|
|
10
|
Asundi J, Reed C, Arca J, et al: An
antibody-drug conjugate targeting the endothelin B receptor for the
treatment of melanoma. Clin Cancer Res. 17:965–975. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cruz-Muñoz W, Jaramillo ML, Man S, et al:
Roles for endothelin receptor B and BCL2A1 in spontaneous CNS
metastasis of melanoma. Cancer Res. 72:4909–4919. 2012.PubMed/NCBI
|
|
12
|
Liu Y, Ye F, Yamada K, et al: Autocrine
endothelin-3/endothelin receptor B signaling maintains cellular and
molecular properties of glioblastoma stem cells. Mol Cancer Res.
9:1668–1685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knight LJ, Burrage J, Bujac SR, et al:
Epigenetic silencing of the endothelin-B receptor gene in non-small
cell lung cancer. Int J Oncol. 34:465–471. 2009.PubMed/NCBI
|
|
14
|
Puglisi MA, Barba M, Corbi M, et al:
Identification of Endothelin-1 and NR4A2 as
CD133-regulated genes in colon cancer cells. J Pathol. 225:305–314.
2011.PubMed/NCBI
|
|
15
|
Sørby LA, Kleiveland CR, Andersen SN,
Bukholm IR and Jacobsen MB: The endothelin axis in the metastatic
process of colon carcinoma. Anticancer Res. 31:861–869.
2011.PubMed/NCBI
|
|
16
|
Wang R, Löhr CV, Fischer K, et al:
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon
cancer. Int J Cancer. 132:1004–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao K, Wu C, Wu K, et al: Quantitative
analysis of promoter methylation of the EDNRB gene in gastric
cancer. Med Oncol. 29:107–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishimoto S, Wada K, Tanaka N, et al: Role
of endothelin receptor signalling in squamous cell carcinoma. Int J
Oncol. 40:1011–1019. 2012.PubMed/NCBI
|
|
19
|
Hase R, Miyamoto M, Uehara H, et al:
Pigment epithelium-derived factor gene therapy inhibits human
pancreatic cancer in mice. Clin Cancer Res. 11:8737–8744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Evans NJ and Walker JW: Endothelin
receptor dimers evaluated by FRET, ligand binding, and calcium
mobilization. Biophys J. 95:483–492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klammt C, Srivastava A, Eifler N, et al:
Functional analysis of cell-free-produced human endothelin B
receptor reveals transmembrane segment 1 as an essential area for
ET-1 binding and homodimer formation. FEBS J. 274:3257–3269. 2007.
View Article : Google Scholar
|
|
22
|
Elshourbagy NA, Adamou JE, Gagnon AW, Wu
HL, Pullen M and Nambi P: Molecular characterization of a novel
human endothelin receptor splice variant. J Biol Chem.
271:25300–25307. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shyamala V, Moulthrop TH, Stratton-Thomas
J and Tekamp-Olson P: Two distinct human endothelin B receptors
generated by alternative splicing from a single gene. Cell Mol Biol
Res. 40:285–296. 1994.PubMed/NCBI
|
